What is the right tool for 24/7 pain? Having the right tool for the job can mean the difference between being on a roller coaster of uncontrolled pain versus being on a merry-go-round of good pain control. Pain medications have two basic methods for delivering the active ingredient: immediate release or sustained release.
Immediate release medications are designed for occasional, temporary pain because they work fast but don't last. This allows a person to use these short-acting medications like Vicodin , Lortab , and Percocet "as needed for pain" (this is a common instruction on prescription bottles). However, many people end up using quick-acting medications constantly, around-the-clock for 24/7 pain. That is like trying to use a hammer as if it were a nail. Immediate release medications are the wrong tools for the job of controlling constant pain. Because these medications wear-off so quickly, one never has a chance to stay ahead of the pain. Instead, this roller coaster...
A study recently published in the journal Evidence-Based Complementary and Alternative Medicine found that myofascial release therapy significantly improved many of the symptoms of fibromyalgia including pain, sleep quality, anxiety and quality of life. Myofascial release therapy (MRT) is a type of massage that applies very gentle sustained pressure to various parts of the body in order to release fascial restrictions. Study Design Fibromyalgia patients were divided into two groups. The experimental group, consisting of 30 individuals, received 90-minute MRT sessions once a week for 20 weeks. The control group of 29 individuals received a weekly 30-minute session of disconnected magnetotherapy for 20 weeks. (Patients in the control group did not know they were receiving a sham therapy.) The following instruments were used to measure symptom severity:
Pain – Visual Analog Scale
Anxiety – State-Trait Anxiety Inventory
Depression – Be...
Earlier this month, the FDA's Anesthetic and Analgesic Drug Products Advisory Committee overwhelmingly voted against recommending approval of Zohydro ER, an extended-release version of hydrocodone. If approved, Zohydro ER would have been the first hydrocodone medication available that did not also contain a non-opioid analgesic such as acetaminophen or ibuprofen.
While the FDA does not have to follow the recommendation of its advisory committee, it usually does. The final determination is expected to be made by March 1, 2013.
Despite the fact that Zohydro ER was studied in nearly 1,500 patients––some for as long as a year––and found to be generally safe and well-tolerated with no new or unexpected safety problems, panel members expressed concerns with potential abuse, addiction and long-term safety.
It was noted that the manufacturer didn't offer any solution as to how they would limit unintended use other than the already tight distributio...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.